Viewing Study NCT05995392


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-01-05 @ 5:55 PM
Study NCT ID: NCT05995392
Status: UNKNOWN
Last Update Posted: 2023-08-21
First Post: 2023-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease
Sponsor: Richard W Yee, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module